» Articles » PMID: 39933949

A Novel Histone Deacetylase 6 Inhibitor, 4-FHA, Improves Scopolamine-Induced Cognitive and Memory Impairment in Mice

Overview
Specialty Pharmacology
Date 2025 Feb 11
PMID 39933949
Authors
Affiliations
Soon will be listed here.
Abstract

Although histone deacetylase 6 (HDAC6) is considered a therapeutic target for Alzheimer's disease (AD), its role in cholinergic dysfunction in AD patients remains unclear. This study investigated the effects of ()-3-(2-(4-fluorostyryl)thiazol-4-yl)--hydroxypropanamide (4-FHA), a new synthetic HDAC6 inhibitor, on cognitive and memory impairments in a scopolamine-induced-AD mouse model. Behaviorally, 4-FHA improved scopolamine-induced memory impairments in the Y-maze, passive avoidance, and Morris water maze tests. In addition, 4-FHA ameliorated scopolamine-induced cognitive impairments in the novel object recognition and place recognition tests. Furthermore, 4-FHA increased acetylation of α-tubulin (a major HDAC6 substrate); the expression of BDNF; and the phosphorylation of ERK 1/2, CREB, and ChAT in the hippocampus of scopolamine-treated mice. In summary, according to our data 4-FHA, an HDAC6 inhibitor, improved the cognitive and memory deficits of the AD mouse model by normalizing BDNF signaling and synaptic transmission, suggesting that 4-FHA might be a potential therapeutic candidate for AD.

References
1.
Park H, Kwon H, Lee J, Cho E, Lee Y, Moon M . β-Amyrin Ameliorates Alzheimer's Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus. Biomol Ther (Seoul). 2019; 28(1):74-82. PMC: 6939697. DOI: 10.4062/biomolther.2019.024. View

2.
Ding Y, Kang A, Tang Q, Zhao Y . Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and Aβ co‑aggregation in rats. Mol Med Rep. 2019; 20(4):3363-3370. DOI: 10.3892/mmr.2019.10571. View

3.
Therriault J, Zimmer E, Benedet A, Pascoal T, Gauthier S, Rosa-Neto P . Staging of Alzheimer's disease: past, present, and future perspectives. Trends Mol Med. 2022; 28(9):726-741. DOI: 10.1016/j.molmed.2022.05.008. View

4.
Kim B, Jha S, Seo J, Jeong C, Lee S, Lee S . MeBib Suppressed Methamphetamine Self-Administration Response via Inhibition of BDNF/ERK/CREB Signal Pathway in the Hippocampus. Biomol Ther (Seoul). 2020; 28(6):519-526. PMC: 7585641. DOI: 10.4062/biomolther.2020.041. View

5.
Dompierre J, Godin J, Charrin B, Cordelieres F, King S, Humbert S . Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci. 2007; 27(13):3571-83. PMC: 6672116. DOI: 10.1523/JNEUROSCI.0037-07.2007. View